An SCRS Global Impact Partner, Parexel provides comprehensive drug development capabilities to help clients get their new and innovative drug treatments into the hands that need them most. We simplify the journey to market through our global regulatory expertise, Phase I-IV clinical research services, integrated eClinical technologies, and commercialization services. For more information, visit www.Parexel.com.